{"interviewQueryText":"What are some good interview questions in British English for the job description below?\n\n-------------------------------------------\n\nConsultant Clinical Oncologist GU & Sarcoma with The Christie NHS Foundation Trust in Manchester, United Kingdom\n\n Detailed job description and main responsibilities This post is for 10 Programmed Activities (PAs) per week to work within the Clinical Oncology urology and sarcoma group and proton beam therapy team. The outpatient clinics will be held at both at The Christie main site and Stepping Hill Hospital Role Purpose This is a replacement 10PA post. It is envisaged that the post-holder will have clinical commitments in both Urological and Sarcoma oncology, being actively involved in these disease groups, as well as being involved in the national delivery of proton beam therapy (PBT) for complex bone and soft tissue sarcomas. The appointee will be expected to develop a significant interest in both GU and Sarcoma delivering both radiotherapy, and systemic therapy. The appointee will be a member of the South sector (Stockport-Tameside-Macclesfield) urology MDT and also the sarcoma MDT. As such they will be expected to do two weekly clinics at Christie (one sarcoma and one urology), a weekly GU peripheral clinic at Stepping Hill Hospital and participate in person at both weekly MDTs. One is presently at Stepping Hill Hospital but may later move to Christie Hospital (GU) and the other is the weekly GMOSS MDT hosted by MFT DUTIES AND RESPONSIBILITIES Urology The appointee will be expected to develop a significant urology interest delivering both radiotherapy and systemic therapy. The post involves a weekly peripheral clinic at Stepping Hill Hospital and a clinic at Christie. The peripheral clinic will involve seeing new and complex follow up patients and having oversight of a parallel nurse led clinic delivering novel hormone therapies. At present any patients requiring intravenous systemic therapy will be transferred to the Christie site to receive this treatment. The post holder will join a large team of 8 Clinical Oncology consultants specialising in Urological cancer these are: Dr James Wylie (lead Clinician) Dr Ananya Choudhury Dr Ruth Conroy Dr Andrew Hudson Dr John Logue Dr Maria Serra Dr Yee Pei Song Dr Anna Tran The appointee will serve the South sector MDT (Stockport-Tameside-Macclesfield) together with Dr Logue. This will include attendance at the specialist Urology MDT. In the last year the urology team have seen approximately 1100 new patients. The south sector uro-oncology service is an established team comprising 2 clinical oncologists, 12 urologists (3 performing level 2 surgery), 2 pathologists, 3 radiologists and clinical nurse specialists on all 3 sites in addition to an MDT co-ordinator. The Clinical Oncology Urology group provide a comprehensive range of treatment options including VMAT/IGRT, LDR/HDR brachytherapy, prostate SABR, oligometastatic SABR and delivery of radionuclide therapies e.g. Ra223. The provision of chemotherapy for prostate and urothelial cancers is delivered by the clinical oncology team with renal cancer and testicular cancer systemic therapies undertaken by the medical oncology team. The urology group has an established record in radiotherapy related research, the delivery of clinical trials and has a broad portfolio of commercial and academic phase 2-3 studies. Radiotherapy related research is led by Professor Ananya Choudhury and the urology team have monthly multi-disciplinary radiotherapy research meetings with regular attendance by radiographers, physicists and clinicians. There is also a monthly research seminar at which all on going research is presented by surgical, radiotherapy and systemic teams. Systemic and novel agent clinical trials are led by Dr A Hudson. The GU clinical oncology group has an active research programme with a Phase I/II/III trial portfolio delivering research studies to ~150-200 patients per year. The research team comprises 5 experienced research nurses and 6 clinical trials administrators. This role may include the setting up of radiotherapy trials or clinical developments involving advanced radiotherapy techniques such as SABR, or MR Linac. Sarcoma The postholder will be joining the Sarcoma clinical oncology consultant team and this consists of the following doctors: Dr James Wylie (Lead Clinician) Dr Mohammed Khalid Abutaleb Dr Abiola Fatimilehin These consultants who share responsibility for the delivery of radiotherapy for bone and soft tissue sarcoma. There is a weekly multidisciplinary sarcoma clinic involving Consultant Onco-plastic surgeons (Mr D Mowatt and Mr Damir Kosutic). Approximately 100 cases per annum receive radical radiotherapy. Dr A Lee and Dr Hameed share responsibility for any chemotherapy delivered for sarcoma and they run a weekly parallel clinic. Approximately 150 new cases of sarcoma are currently seen at The Christie per year. The Greater Manchester and Oswestry Sarcoma Service (GMOSS) is based primarily around three Hospitals, namely Manchester University NHS Foundation Trust (MFT), Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust (RJAH), and The Christie NHS Foundation Trust. GMOSS provide specialist care for patients with all types and stages of soft tissue and bone sarcoma residing in the Greater Manchester, Cheshire, parts of Greater Midlands, and North Wales. Patients with bone sarcoma and teenage and young adult patients with sarcoma residing in the Lancashire and South Cumbria Cancer Network (LSCCN) are referred into GMOSS. The core service comprises five sarcoma surgeons, two medical oncologists, two clinical oncologists, one dedicated TYA oncologist, three musculo-skeletal radiologists, two specialist sarcoma pathologists plus two clinical nurse specialists (CNS) at Christie as well as nurses at MFT and Oswestry all with a special interest in sarcoma. The sarcoma service screens and recruits patients to clinical trials and is assisted by a clinical trials nurse. A core weekly multi-disciplinary team meeting (MDT) between the sites is held where all confirmed new, highly suspected or recurrent sarcoma cases are discussed to formulate a management plan. The MDT is video linked between the three sites The team is also responsible for delivery of proton beam therapy (PBT) for TYA and adult patients fulfilling the NHS criteria for this treatment. Broadly this includes patients with para-spinal and spinal sarcomas, truncal and pelvic Ewings and complex head and neck sarcomas including rhabdomyosarcoma. The well supported team structure can provide training and mentorship in PBT planning and delivery and prior experience is not a pre-requisite. The postholder will be expected to see approximately 160 new patients per year across both disease sites. Person specification Attainments Essential criteria MRCR or equivalent qualification Entry on the General Medical Council (GMC) specialist register via one of the following: a. Certificate of Completion of Training (CCT) (the proposed CCT date must be within 6 months of interview) b. Certificate of Eligibility for Specialist Registration (CESR) Evidence of productive ethical research relevant to oncology Desirable criteria An appropriate higher degree Recent publications in peer-reviewed journals Training Essential criteria Wide experience of Oncology including GU and Sarcoma Cancer Desirable criteria An appropriate higher degree Experience Essential criteria Appropriate experience across all disease groups in Clinical Oncology Experience in teaching undergraduates Experience of clinical audit Desirable criteria Research experience Relevant experience Teaching Essential criteria Evidence of contribution to teaching Desirable criteria Teaching experience /training Personal Skills Essential criteria Is a team player prepared to adapt to changing circumstances. Evidence of clinical leadership skills Proven ability to lead a team Dynamic, decision-making motivator. Integrity, management and communication skills including teaching. Confident in ability, but knowing own limitations. Demonstrates knowledge, logic and efficiency. Excellent written and oral communication skills. Flexibility, commitment and team work with colleagues and staff in the department. Hardworking, enthusiastic achiever. Good attendance record. Patient friendly. Professional demeanour Must be resilient and well organised. Ability to work under pressure Self-motivator and able to motivate team The closing date for this post may be extended if there are insufficient applicants or brought forward if there is a high volume of applicants. We want to ensure that everyone who works at the Christie or uses our services is welcomed, valued and treated with dignity and respect. The Christie values diversity and is committed to ensuring equal opportunities for all and fair representation across the organisation at all levels. In support of these commitments, we particularly welcome applications from Black, Asian and other ethnic minority people and people with disabilities for this post. Appointment will be only on merit. We are committed to creating a balanced and diverse workforce. As such we welcome and encourage applications from people of all backgrounds. Together we will foster inclusion and tackle inequity and health inequalities in cancer care. As users of the disability confident scheme, we guarantee to interview all disabled applicants who meet the minimum criteria for the vacancy All positions within the Christie are subject to the receipt of satisfactory written references, medical clearance and evidence of your Right to Work in the UK. Some roles will require a Disclosure & Barring Service (DBS) check. Please note if you are successfully appointed to a post with this Trust, you will be required to pay for your own DBS Disclosure. By applying for this post you are agreeing to The Christie NHS Foundation Trust transferring the information contained in this application to its preferred applicant management system. If you are offered a job information will also be transferred into the national NHS Electronic Staff Records system. Please note, all communication regarding your application will be made via email, please ensure you check your junk/spam folders as emails are sometimes filtered there. If you have not heard from us within four weeks of the closing date, I regret that on this occasion your application will have been unsuccessful. The Inter-Authority Transfer (IAT) process is a critical and beneficial component of ESR and will form part of the recruitment process. In the event that you are successful following interview your previous NHS employment data, if applicable will be transferred from your current / most recent employer. Overseas candidates wishing to apply for this position and who would require immigration sponsorship, may wish to self-assess the likelihood of obtaining a Certificate of Sponsorship for the post on the UKVI website. You should be aware the Trust operates a No Smoking Policy and therefore employees are not permitted to smoke at work. Employer certification / accreditation badges Applicant requirements You must have appropriate UK professional registration. This post is subject to the Rehabilitation of Offenders Act 1974 (Exceptions) Order 1975 (Amendment) (England and Wales) Order 2020 and it will be necessary for a submission for Disclosure to be made to the Disclosure and Barring Service. Documents to download JD & PS (PDF, 374.7KB) The Christie Values and Behaviours (PDF, 919.5KB) Strategy Brochure (PDF, 1.0MB) Trust Membership - Christie Talent (PDF, 23.0KB) Travel to The Christie (PDF, 3.8MB) "}